Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Globus Medical Inc (NYSE: GMED) closed at $50.37 down -2.08% from its previous closing price of $51.44. In other words, the price has decreased by -$2.08 from its previous closing price. On the day, 0.61 million shares were traded. GMED stock price reached its highest trading level at $51.4 during the session, while it also had its lowest trading level at $50.02.
Ratios:
For a deeper understanding of Globus Medical Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.27. For the most recent quarter (mrq), Quick Ratio is recorded 2.72 and its Current Ratio is at 4.88. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.13.
On October 20, 2023, ROTH MKM started tracking the stock assigning a Buy rating and target price of $75.
Stifel Upgraded its Hold to Buy on September 19, 2023, while the target price for the stock was maintained at $61.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Mar 15 ’24 when Norwalk Leslie V sold 10,590 shares for $51.99 per share. The transaction valued at 550,574 led to the insider holds 17,419 shares of the business.
Huller Kelly sold 7,500 shares of GMED for $405,730 on Mar 01 ’24. The SVP, GC, Corporate Secretary now owns 0 shares after completing the transaction at $54.10 per share. On May 15 ’23, another insider, Lemaitre Dan, who serves as the Director of the company, sold 43,450 shares for $56.98 each. As a result, the insider received 2,475,977 and left with 10,800 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GMED now has a Market Capitalization of 6963551744 and an Enterprise Value of 6822134272. As of this moment, Globus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 43.25, and their Forward P/E ratio for the next fiscal year is 15.25. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.35 while its Price-to-Book (P/B) ratio in mrq is 1.72. Its current Enterprise Value per Revenue stands at 4.35 whereas that against EBITDA is 16.312.
Stock Price History:
Over the past 52 weeks, GMED has reached a high of $62.88, while it has fallen to a 52-week low of $43.38. The 50-Day Moving Average of the stock is -5.10%, while the 200-Day Moving Average is calculated to be -4.21%.
Shares Statistics:
For the past three months, GMED has traded an average of 1.04M shares per day and 913390 over the past ten days. A total of 113.91M shares are outstanding, with a floating share count of 112.02M. Insiders hold about 17.25% of the company’s shares, while institutions hold 80.34% stake in the company. Shares short for GMED as of 1713139200 were 7508883 with a Short Ratio of 7.20, compared to 1710460800 on 5857052. Therefore, it implies a Short% of Shares Outstanding of 7508883 and a Short% of Float of 6.7.
